| Literature DB >> 31618910 |
Paulo Estevão Franco-Alvarenga1,2, Cayque Brietzke1, Raul Canestri1, Márcio Fagundes Goethel1, Bruno Ferreira Viana1,3, Flávio Oliveira Pires4.
Abstract
The central and peripheral effects of caffeine remain debatable. We verified whether increases in endurance performance after caffeine ingestion occurred together with changes in primary motor cortex (MC) and prefrontal cortex (PFC) activation, neuromuscular efficiency (NME), and electroencephalography-electromyography coherence (EEG-EMG coherence). Twelve participants performed a time-to-task failure isometric contraction at 70% of the maximal voluntary contraction after ingesting 5 mg/kg of caffeine (CAF) or placebo (PLA), in a crossover and counterbalanced design. MC (Cz) and PFC (Fp1) EEG alpha wave and vastus lateralis (VL) muscle EMG were recorded throughout the exercise. EEG-EMG coherence was calculated through the magnitude squared coherence analysis in MC EEG gamma-wave (CI > 0.0058). Moreover, NME was obtained as the force-VL EMG ratio. When compared to PLA, CAF improved the time to task failure (p = 0.003, d = 0.75), but reduced activation in MC and PFC throughout the exercise (p = 0.027, d = 1.01 and p = 0.045, d = 0.95, respectively). Neither NME (p = 0.802, d = 0.34) nor EEG-EMG coherence (p = 0.628, d = 0.21) was different between CAF and PLA. The results suggest that CAF improved muscular performance through a modified central nervous system (CNS) response rather than through alterations in peripheral muscle or central-peripheral coupling.Entities:
Keywords: EEG–EMG coherence; ergogenic; fatigue; placebo
Mesh:
Substances:
Year: 2019 PMID: 31618910 PMCID: PMC6836165 DOI: 10.3390/nu11102471
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Changes in time to task failure during submaximal isometric contraction after caffeine (CAF) and placebo (PLA) ingestion. * Indicates significantly different from PLA (p = 0.003). Data are reported as mean ± standard deviation (SD).
Figure 2Electroencephalography (EEG) alpha wave recorded at Cz (A) and Fp1 (B) positions during isometric contraction in CAF (filled square) and PLA (open square) sessions. * Indicates condition main effect in Cz (p = 0.027) and PFC (p = 0.045). # indicates moment main effect in Cz (p = 0.000) and Fp1 (p = 0.001). Data are reported as mean ± SD.
Figure 3Changes in neuromuscular efficiency (NME) of vastus lateralis muscle during isometric contraction in caffeine (CAF) and placebo (PLA) sessions. # Is moment main effect (p = 0.000). Data are reported as mean ± SD.
Figure 4Spectrogram of EEG gamma wave at Cz position and vastus lateralis electromyography (EMG).
Figure 5EEG–EMG coherence in CAF (filled square) and PLA (open square) sessions. Data are reported as mean ± SD.
Mean (±SD) and 95% confidence interval (95% CI) for dependent variables.
| Time of Exercise | |||||
|---|---|---|---|---|---|
| Ingestion | Dependent Variable | 25% | 50% | 75% | 100% |
|
| Prefrontal EEG | 40.9 ± 54.0 | 49.4 ± 43.2 | 75.7 ± 16.0 | 86.7 ± 12.9 |
| 95% CI | (−507.5–245.1) | (−60.2–93.6) | (−187.8–80.2) | (−366.9–274.2) | |
| Motor Cortex EEG | −311.8 ± 634.7 | −95.6 ± 184.4 | −99.9 ± 197.1 | 33.1 ± 75.2 | |
| 95% CI | (−176.6–62.6) | (−216.1–19.1) | (−185.7–46.1) | (22.2–88.3) | |
| NME | 0.03 ± 0.01 | 0.02 ± 0.01 | 0.02 ± 0.01 | 0.03 ± 0.01 | |
| 95% CI | (0.01–0.04) | (0.01–0.04) | (0.01–0.03) | (0.01–0.03) | |
| EEG–EMG Coherence | 0.06 ± 0.05 | 0.04 ± 0.02 | 0.04 ± 0.02 | 0.06 ± 0.06 | |
| 95% CI | (0.02–0.06) | (0.02–0.05) | (0.02–0.03) | (0.02–0.06) | |
|
| Prefrontal EEG | 70.2 ± 22.9 | 64.9 ± 36.3 | 80.1 ± 21.1 | 92.1 ± 11.6 |
| 95% CI | (45.2–96.8) | (2.7–84.3) | (33.1–104.3) | (81.6–102.3) | |
| Motor Cortex EEG | −27.0 ± 148.9 | −80.7 ± 191.9 | −10.3 ± 150.3 | 66.2 ± 57.5 | |
| 95% CI | (57.0–88.6) | (−165.7–79.6) | (−109.1–121.1) | (66.4–107.4) | |
| NME | 0.03 ± 0.01 | 0.02 ± 0.01 | 0.02 ± 0.01 | 0.02 ± 0.01 | |
| 95% CI | (0.01–0.06) | (0.01–0.05) | (0.01–0.04) | (0.01–0.04) | |
| EEG–EMG Coherence | 0.06 ± 0.06 | 0.04 ± 0.03 | 0.09 ± 0.09 | 0.05 ± 0.05 | |
| 95% CI | (0.02–0.06) | (0.02–0.06) | (0.03–0.08) | (0.02–0.06) | |
NME—neuromuscular efficiency; EEG—electroencephalography; EMG—electromyography; CAF—caffeine; PLA—placebo.